3,4-Methylenedioxy-N-isopropylamphetamine

3,4-Methylenedioxy-N-isopropylamphetamine (MDIP, MDIPA) is a psychoactive drug of the phenethylamine and amphetamine chemical classes which acts as an entactogen, psychedelic, and stimulant. It is the N-isopropyl analogue of 3,4-methylenedioxyamphetamine (MDA). MDIP was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 250 mg.[1] MDIP produces a mild threshold. Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of MDIP.

3,4-Methylenedioxy-N-isopropylamphetamine
Names
Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-N-(propan-2-yl)propan-2-amine
Other names
3,4-Methylenedioxy-N-isopropylamphetamineamine
3,4-Methylenedioxy-1-(alpha-methyl-amino-isopropyl)-ethane
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C13H19NO2/c1-9(2)14-10(3)6-11-4-5-12-13(7-11)16-8-15-12/h4-5,7,9-10,14H,6,8H2,1-3H3
    Key: XKEVWMVUIDDRMC-UHFFFAOYSA-N
  • C1=C2C(=CC=C1CC(C)NC(C)C)OCO2
Properties
C13H19NO2
Molar mass 221.300 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

References
  1. MDIP entry in PiHKAL


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.